First antibiotic in new class of drugs fights resistant infections.
D000081:Acetamides / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017277:Drug Approval; D004352:Drug Resistance, Microbial; D016984:Enterococcus faecium / Q000187:drug effects; D000069349:Linezolid; D016106:Methicillin Resistance; D023303:Oxazolidinones / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration; D014640:Vancomycin / Q000627:therapeutic use
D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D014640:Vancomycin; D000069349:Linezolid